“Drug Pricing”

15 result(s)
Cost Management
It's time to bust the myth about drug prices and rebates. Larry Merlo, President and CEO shared CVS Health’s perspective as an employer and PBM in an op-ed. More
Commentary
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary
Cost Management
With prescription drug prices very much in the news, the question often asked is: Who is responsible for high drug prices? Pharmaceutical manufacturers — and no one else — set... More
Commentary
Cost Management
Our formulary strategies effectively leverage competition in the pharmaceutical market to help reduce costs and trend for PBM clients. More
Video
Cost Management
We want clients and members to get the most out of their benefit and the cost of a drug is aligned with the value it delivers. Despite AWP inflation near 10%, we kept drug price... More
Feature
Pharmacy Innovation
Point-of-sale rebates and zero-dollar copay plans can help alleviate the impact of high drug costs for members in HDHPs during the deductible phase. More
Commentary
Expensive Pill
Cost Management
Value-based management can only deliver on their promise of incremental cost-savings if the right guardrails are in place to ensure appropriate utilization and management. More
Briefing
Measuring Success
Cost Management
A few key metrics can help demonstrate how well a value-based management approach is working in helping align drug prices with the value and outcomes they deliver. More
Briefing
Aligning Drug Prices with Value
Cost Management
The current model of static, manufacturer-set drug prices is simply unsustainable. Value-based management approaches attempt to incentivize quality and efficacy. More
Briefing
Public Policy
A focus on prioritizing generic review and fostering competition could help in the battle against sky-rocketing prescription drug costs. More
Commentary